Advertisement
Advertisement
MRK
Merck & Co., Inc.
130.42
USDSponsored
-0.50
-0.38%
Aug 11, 16:00 UTC -4
Closed
After-Market
130.45
+0.03
+0.02%
MRK Earnings Reports
Positive Surprise Ratio
MRK beat 36 of 42 last estimates.
86%
Next Report
Date of Next Report
Oct 29, 2026
Estimate for Q3 26 (Revenue/ EPS)
$17.49B
/$2.24
Implied change from Q2 26 (Revenue/ EPS)
+5.30%
/-1823.08%
Implied change from Q3 25 (Revenue/ EPS)
+1.22%
/-16.42%
Merck & Co., Inc. earnings per share and revenue
On Aug 04, 2026, MRK reported earnings of -0.13 USD per share (EPS) for Q2 26, beating the estimate of -0.27 USD, resulting in a 52.33% surprise. Revenue reached 16.61 billion, compared to an expected 16.54 billion, with a 0.41% difference. The market reacted with a +0.18% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 12 analysts forecast an EPS of 2.24 USD, with revenue projected to reach 17.49 billion USD, implying an decrease of -1823.08% EPS, and increase of 5.30% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Eli Lilly & Co.
Report Date
Aug 05, 2026 For Q2 26
Estimate
$6.06
Actual
$8.38
Surprise
+38.14%
ABBVIE INC.
Report Date
Jul 31, 2026 For Q2 26
Estimate
$3.67
Actual
$3.65
Surprise
-0.71%
Novo-Nordisk A/S
Report Date
Aug 04, 2026 For Q2 26
Estimate
$5.03
Actual
$4.75
Surprise
-5.65%
Pfizer Inc.
Report Date
Aug 04, 2026 For Q2 26
Estimate
$0.69
Actual
$0.77
Surprise
+11.37%
Sanofi - ADR
Report Date
Jul 30, 2026 For Q2 26
Estimate
$1.91
Actual
$2.09
Surprise
+8.91%
Innoviva, Inc. Common Stock
Report Date
Aug 05, 2026 For Q2 26
Estimate
$0.44
Actual
-$1.13
Surprise
-356.35%
FAQ
What were Merck & Co., Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Merck & Co., Inc. reported EPS of -$0.13, beating estimates by 52.33%, and revenue of $16.61B, 0.41% above expectations.
How did the market react to Merck & Co., Inc.'s Q2 2026 earnings?
The stock price moved up 0.18%, changed from $127.77 before the earnings release to $128.00 the day after.
When is Merck & Co., Inc. expected to report next?
The next earning report is scheduled for Oct 29, 2026.
What are the forecasts for Merck & Co., Inc.'s next earnings report?
Based on 12
analysts, Merck & Co., Inc. is expected to report EPS of $2.24 and revenue of $17.49B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement